Second-line systemic therapy in patients with recurrent or metastatic adenoid cystic carcinoma

被引：0
作者：
Kadowaki, Shigenori [1 ]
Nakazawa, Taiko [1 ]
Ogata, Takatsugu [1 ]
Matsubara, Yuki [1 ]
Nozawa, Kazuki [1 ]
Kato, Kyoko [1 ]
Narita, Yukiya [1 ]
Honda, Kazunori [1 ]
Masuishi, Toshiki [1 ]
Bando, Hideaki [1 ]
Ando, Masashi [1 ]
Hanai, Nobuhiro [2 ]
Muro, Kei [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
[2] Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.621
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO22-6
引用
收藏
页码：S312 / S312
页数：1
相关论文
共 50 条
  • [41] Second-line systemic therapy for esophageal cancer
    Martin, M. G.
    Wang-Gillam, A.
    Waqar, M. A.
    Fong, T. H.
    Gao, F.
    Govindan, R.
    Morgensztern, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Second-line therapy for metastatic colorectal cancer
    Price, Timothy J.
    LANCET ONCOLOGY, 2015, 16 (05) : 476 - 477
  • [43] Second-line chemotherapy in older patients with metastatic urothelial carcinoma: Pooled analysis of 10 second-line studies.
    Salah, Samer
    Lee, Jae-Lyun
    Rozzi, Antonio
    Lewin, Jeremy Howard
    Kitamura, Hiroshi
    Matsumoto, Kazumasa
    Vis, Daniel J.
    Wessels, Lodewyk F. A.
    Srinivas, Sandy
    Morales, Rafael
    Carles, Joan
    Toubasi, Samar
    Lee, Soonil
    Kim, Ki Hong
    Izumi, Kouji
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma
    Desilets, Antoine
    Vos, Joris L.
    Katabi, Nora
    Kuo, Fengshen
    Nadeem, Zaineb
    Linxweiler, Maximilian
    Ostrovnaya, Irina
    Baxi, Shrujal
    Dunn, Lara A.
    Sherman, Eric J.
    Pfister, David G.
    Morris, Luc G. T.
    Ho, Alan L.
    CLINICAL CANCER RESEARCH, 2024, 30 (23) : 5281 - 5292
  • [45] Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma
    Pantalone, Mattia Russel
    Rahbar, Afsar
    Soderberg-Naucler, Cecilia
    Stragliotto, Giuseppe
    CANCERS, 2022, 14 (08)
  • [46] Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma
    Rao, RD
    Holtan, SG
    Ingle, JN
    Croghan, GA
    Kottschade, LA
    Creagan, ET
    Kaur, JS
    Pitot, HC
    Markovic, SN
    CANCER, 2006, 106 (02) : 375 - 382
  • [47] A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma.
    Tchekmedyian, Vatche
    Sherman, Eric Jeffrey
    Dunn, Lara
    Tran, Crystal
    Katabi, Nora
    Ni, Ai
    Haque, Sofia
    Pfister, David G.
    Ho, Alan Loh
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma
    Ferrarotto, Renata
    Sousa, Luana G.
    Feng, Lei
    Mott, Frank
    Blumenschein, George
    Altan, Mehmet
    Bell, Diana
    Bonini, Flavia
    Li, Kaiyi
    Marques-Piubelli, Mario L.
    Dal Lago, Eduardo A.
    Johnson, Jason J.
    Mitani, Yoshitsugu
    Godoy, Myrna
    Lee, Anna
    Kupferman, Michael
    Hanna, Ehab
    Glisson, Bonnie S.
    Elamin, Yasir
    El-Naggar, Adel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (15) : 2843 - +
  • [49] Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma
    Dodd, PM
    McCaffrey, JA
    Mazumdar, M
    Icasiano, E
    Higgins, G
    Herr, H
    Bajorin, DF
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (03) : 247 - 251
  • [50] Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting
    Procopio, Giuseppe
    Derosa, Lisa
    Gernone, Angela
    Morelli, Franco
    Sava, Teodoro
    Zustovich, Fable
    De Giorgi, Ugo
    Ferrari, Vittorio
    Sabbatini, Roberto
    Gasparro, Donatello
    Felici, Alessandra
    Burattini, Luciano
    Calvani, Nicola
    Lo Re, Giovanni
    Banna, Giuseppe
    Brizzi, Maria Pia
    Rizzo, Mimma
    Ciuffreda, Libero
    Iacovelli, Roberto
    Ferrau, Francesco
    Taibi, Eleonora
    Bracarda, Sergio
    Porta, Camillo
    Galligioni, Enzo
    Contu, Antonio
    FUTURE ONCOLOGY, 2014, 10 (10) : 1741 - 1750
12345